Cancer and Hematology Centers of Western Michigan Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Cancer and Hematology Centers of Western Michigan's estimated annual revenue is currently $131.6M per year.(i)
  • Cancer and Hematology Centers of Western Michigan's estimated revenue per employee is $337,500

Employee Data

  • Cancer and Hematology Centers of Western Michigan has 390 Employees.(i)
  • Cancer and Hematology Centers of Western Michigan grew their employee count by 15% last year.

Cancer and Hematology Centers of Western Michigan's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Director OperationsReveal Email/Phone
3
Senior Director, Clinical OperationsReveal Email/Phone
4
Accounts Receivable SpecialistReveal Email/Phone
5
PHYSICIANSReveal Email/Phone
6
PHYSICIAN EXECUTIVE Reveal Email/Phone
7
PHYSICIAN EXECUTIVE Reveal Email/Phone
8
PHYSICIAN EXECUTIVE Reveal Email/Phone
9
ADMINISTRATIVEReveal Email/Phone
10
PHYSICIANReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.3M346%N/AN/A
#2
$165M4893%N/AN/A
#3
$3.5M15834%N/AN/A
#4
$6711M177547%N/AN/A
#5
$7.3M346%N/AN/A
#6
$71M239-1%N/AN/A
#7
$224.1M66419%N/AN/A
#8
$54.4M1835%N/AN/A
#9
$20.5M763%N/AN/A
#10
$56.4M14737%N/AN/A
Add Company

What Is Cancer and Hematology Centers of Western Michigan?

Cancer & Hematology Centers of Western Michigan is the largest private oncology/hematology medical practice in Michigan. We provide our patients with advanced treatments, innovative research and, above all else, compassionate care.

keywords:N/A

N/A

Total Funding

390

Number of Employees

$131.6M

Revenue (est)

15%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Cancer and Hematology Centers of Western Michigan News

2022-04-20 - Online initiative addresses cancer disparities in HIV patients

Fourth-year medical school student Allison Graeter said cancer research has historically excluded those with HIV due to concerns that they would...

2022-04-20 - Study finds lower levels of melatonin in men with prostate cancer

This work is part of the CAPLIFE (prostate cancer and lifestyles) Study (principal investigator: Rocío Olmedo Requena of the UGR's Department of...

2022-04-20 - Biomarker bill could expand cancer testing

Tests to find the right treatment for specific cancers would have to be covered by insurance under a bill recently introduced in the Ohio General Assembly.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$132.6M39316%N/A
#2
$140.1M41511%N/A
#3
$172M4265%N/A
#4
$137.1M4376%N/A
#5
$150.2M44512%N/A